bispecific antibodies: late side effects
Published 11 months ago • 953 plays • Length 5:06Download video MP4
Download video MP3
Similar videos
-
5:44
bispecific antibodies: early side effects
-
4:26
what are bispecific antibodies?
-
3:25
what should myeloma patients know about bispecific antibodies?
-
4:01
what are the differences between car t-cell therapy and bispecific antibodies?
-
4:45
bispecifics part 2: monoclonal and bispecific antibodies
-
4:22
what are the side effects and difficulties with new myeloma immune therapies?
-
1:04:12
a promising future for treating multiple myeloma with bispecific antibodies
-
2:47
what are bispecific antibodies?
-
6:09
bispecific antibodies | high impact topic (hit)
-
7:06
efficacy and safety of elranatamab bcma-cd3 bispecific antibody, in patients with rrmm
-
6:17
myeloma made simple: bispecific antibodies made simple | bispecific antibodies for myeloma treatment
-
57:20
know your myeloma immunotherapy: bispecific antibodies with dr. cesar rodriguez
-
2:43
bispecifics part 4: the science of bispecific antibodies
-
5:32
myeloma made simple: bispecific antibody targets made simple | myeloma targeting with bispecifics
-
5:59
using different targets to destroy multiple myeloma
-
7:25
updated phase 1 results of teclistamab, a bcma × cd3 bispecific antibody, in rrmm
-
7:44
ash23: abbv-383 bcma x cd3 bispecific antibody for relapsed/refractory myeloma | ravi vij, md, mba
-
30:24
faqs on bmca-targeted bispecific antibodies in multiple myeloma
-
1:37
the promise of elranatamab and other bispecifics in the treatment of myeloma